Asia-Pacific Clinical Data Analytics Market by Deployment Model (Cloud, On-Premise), by Services (Consulting, Maintenance), by End Use Sector (Pharmaceuticals, Healthcare Providers, Biotechnology, Academia), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia-Pacific Clinical Data Analytics Market by Deployment Model (Cloud, On-Premise), by Services (Consulting, Maintenance), by End Use Sector (Pharmaceuticals, Healthcare Providers, Biotechnology, Academia), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1757 | Pages: 135 | March 2017 | Region: Asia Pacific


The Asia-Pacific Clinical Data Analytics Market was worth $0.37 billion in 2016 and estimated to be growing at a CAGR of 48.92%, to reach $2.72 billion by 2021. The market is showing significant potential in the mentioned forecasting period. The market continues to grow rapidly with the growth of Big data industry within the healthcare. Big data has been responsible for showing better results in improving healthcare, saving lives and that too at low costs.

Clinical Data Analytics assist physicians and doctors in making decisions related to a patient’s care and help in getting a better knowledge of the healthiness of the demographics. The technology shows variation based on the data required or the potential users of the information which may include any of the nurses, doctors, public health officials etc.

The population is getting more focused towards health management lately. It constitutes for one of the major factors driving the Clinical Data Analytics market. Other factors responsible for the growth of market include supportive government policies, cost benefits and better opportunities to provide high quality services to patients. Some of the challenges and restraints faced by Clinical Data Analytics market include end user market fragmentation, software privacy issues, security issues.

The Asia-Pacific market for Clinical Data Analytics is segmented based on Deployment Model, Services and End Use Sector. Based on the deployment model the market for Clinical Data Analytics is segmented into Cloud and On-Premise. Further, under services the segmentation is done into Consulting and Maintenance, and under End use sector the segmentation is done into Pharmaceuticals, Healthcare Providers, Biotechnology and Academia. On-Premise segmentation accounted for higher share compared to the Cloud segmentation. Similarly Consulting and Pharmaceuticals segmentations exhibit the highest share in their respective segments. On the basis of geographical analysis, the Asia-Pacific market is analysed under various countries namely China, India, Japan, Australia and South Korea.

Some of the companies leading the Clinical Data Analytics market are IBM, Athenahealth, CareEvolution, Caradigm, Cerner, Intersystems, Explorys, Wellcentive, McKesson, Truven Health Analytics.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Deployment Model                                

                                5.1.1 Introduction                           

                                5.1.2 Cloud                         

                                5.1.3 On-Premise                            

                                5.1.4  Y-o-Y Growth Analysis, By Deployment Model                       

                                5.1.5  Market Attractiveness Analysis, By Deployment Model                     

                                5.1.6  Market Share Analysis, By Deployment Model                      

                5.2 Services                                       

                                5.2.1 Introduction                           

                                5.2.2 Consulting                               

                                5.2.3 Maintenance                         

                                5.2.4 Y-o-Y Growth Analysis, By Services                               

                                5.2.5 Market Attractiveness Analysis, By Services                             

                                5.2.6 Market Share Analysis, By Services                              

                5.3 End Use Sector                                         

                                5.3.1 Introduction                           

                                5.3.2 Pharmaceuticals                   

                                5.3.3 Healthcare Providers                          

                                5.3.4 Biotechnology                       

                                5.3.5 Academia                

                                5.3.6 Y-o-Y Growth Analysis, By End Use Sector                 

                                5.3.7  Market Attractiveness Analysis, By End Use Sector                              

                                5.3.8  Market Share Analysis, By End Use Sector                               

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Deployment Model   

                                                6.1.3.3 By Services          

                                                6.1.3.4 By End Use Sector            

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Deployment Model   

                                                6.1.4.3 By Services          

                                                6.1.4.4 By End Use Sector            

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Deployment Model   

                                                6.1.5.3 By Services          

                                                6.1.5.4 By End Use Sector            

                6.2 China                                             

                6.3 India                                              

                6.4 Japan                                            

                6.5 South Korea                                               

                6.6 Australia                                      

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 IBM                                

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 CareEvolution                                            

                8.3 Cardigm                                       

                8.4 Explorys                                       

                8.5 Cerner                                          

                8.6 Intersystems                                             

                8.7 Athenahealth                                            

                8.8 Truven Health Analytics                                        

                8.9 Wellcentive                                

                8.10 McKesson                                 

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Diabetes Care Devices Market By Deployment Model, From 2016-2021 ( USD Million )
  2. Asia-Pacific Cloud Market By Region, From 2016-2021 ( USD Million )
  3. Asia-Pacific On-Premise Market By Region, From 2016-2021 ( USD Million )
  4. Asia-Pacific Diabetes Care Devices Market By Services, From 2016-2021 ( USD Million )
  5. Asia-Pacific Consulting Market By Region, From 2016-2021 ( USD Million )
  6. Asia-Pacific Maintenance Market By Region, From 2016-2021 ( USD Million )
  7. Asia-Pacific Diabetes Care Devices Market By End Use Sector, From 2016-2021 ( USD Million )
  8. Asia-Pacific Pharmaceuticals Market By Region, From 2016-2021 ( USD Million )
  9. Asia-Pacific Healthcare Provider Market By Region, From 2016-2021 ( USD Million )
  10. Asia-Pacific Biotechnology Market By Region, From 2016-2021 ( USD Million )
  11. Asia-Pacific Academia Market By Region, From 2016-2021 ( USD Million )
  12. Japan Diabetes Care Devices Market By Deployment Model, From 2016-2021 ( USD Million )
  13. Japan Diabetes Care Devices Market By Services, From 2016-2021 ( USD Million )
  14. Japan Diabetes Care Devices Market By End Use Sector, From 2016-2021 ( USD Million )
  15. China Diabetes Care Devices Market By Deployment Model, From 2016-2021 ( USD Million )
  16. China Diabetes Care Devices Market By Services, From 2016-2021 ( USD Million )
  17. China Diabetes Care Devices Market By End Use Sector, From 2016-2021 ( USD Million )
  18. India Diabetes Care Devices Market By Deployment Model, From 2016-2021 ( USD Million )
  19. India Diabetes Care Devices Market By Services, From 2016-2021 ( USD Million )
  20. India Diabetes Care Devices Market By End Use Sector, From 2016-2021 ( USD Million )
  21. Australia Diabetes Care Devices Market By Deployment Model, From 2016-2021 ( USD Million )
  22. Australia Diabetes Care Devices Market By Services, From 2016-2021 ( USD Million )
  23. Australia Diabetes Care Devices Market By End Use Sector, From 2016-2021 ( USD Million )
  24. South Korea Diabetes Care Devices Market By Deployment Model, From 2016-2021 ( USD Million )
  25. South Korea Diabetes Care Devices Market By Services, From 2016-2021 ( USD Million )
  26. South Korea Diabetes Care Devices Market By End Use Sector, From 2016-2021 ( USD Million )
Middle East And Africa Mental Health Software Market By Delivery Model (Subscription Models And Ownership Models), By Component (Support Services, Integrated Mental Health Software And Standalone Behavioural Health ...
Latin America Mental Health Software Market By Delivery Model (Subscription Models And Ownership Models), By Component (Support Services, Integrated Mental Health Software And Standalone Behavioural Health Software)...
Asia Pacific Mental Health Software Market By Delivery Model (Subscription Models And Ownership Models), By Component (Support Services, Integrated Mental Health Software And Standalone Behavioural Health Software),...
Europe Mental Health Software Market By Delivery Model (Subscription Models And Ownership Models), By Component (Support Services, Integrated Mental Health Software And Standalone Behavioural Health Software), By En...
North America Mental Health Software Market By Delivery Model (Subscription Models And Ownership Models), By Component (Support Services, Integrated Mental Health Software And Standalone Behavioural Health Software)...
Mental Health Software Market By Delivery Model (Subscription Models And Ownership Models), By Component (Support Services, Integrated Mental Health Software And Standalone Behavioural Health Software), By End User ...
Middle-East And Africa Smart Inhaler Market By Product Type (Nebulizers, Inhalers [Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs)]), Disorder (Chronic Obstructive Pulmonary Disease, Asthma, Other), End-use...
Latin America Smart Inhaler Market By Product Type (Nebulizers, Inhalers [Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs)]), Disorder (Chronic Obstructive Pulmonary Disease, Asthma, Other), End-user (Patien...
Asia-Pacific Smart Inhaler Market By Product Type (Nebulizers, Inhalers [Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs)]), Disorder (Chronic Obstructive Pulmonary Disease, Asthma, Other), End-user (Patient...
Europe Smart Inhaler Market By Product Type (Nebulizers, Inhalers [Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs)]), Disorder (Chronic Obstructive Pulmonary Disease, Asthma, Other), End-user (Patients, R&D...
North America Smart Inhaler Market By Product Type (Nebulizers, Inhalers [Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs)]), Disorder (Chronic Obstructive Pulmonary Disease, Asthma, Other), End-user (Patien...
Smart Inhaler Market By Product Type (Nebulizers, Inhalers [Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs)]), Disorder (Chronic Obstructive Pulmonary Disease, Asthma, Other), End-user (Patients, R&D, Other...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.